Synoptics introduces the Advanced Technology Group to allow access to expertise of designing and commercialising imaging systems

Synoptics, a world leader in the development and manufacture of innovative digital imaging systems for life science applications, today announced it has set up the Advanced Technology Group, a new division within Synoptics which will work with life science companies and academic clients to deliver bespoke imaging equipment to improve bench-based research, quality control or clinical development processes.

Synoptics, comprising the Syngene, Synbiosis and Syncroscopy divisions, provides innovative products that life scientists need to enhance the quality and speed of their research. Syngene, the largest division, produces state-of-the-art equipment including the G:BOX image analyser to analyse gels and blots in the fields of genomics and proteomics. Synbiosis provides the ProtoCOL 2, a gold standard colony counting and zone sizing system used in many major pharmaceutical companies and Syncroscopy offers Auto-Montage software for producing focused images of 3D samples, which is marketed by major microscope manufacturer, Leica.

Richard Maskell, Synoptics’ new head of the Advanced Technology Group explained: “We are increasingly being approached to develop novel systems and software to bring about a step change in biological quality control and research processes. We have experience in solving challenges associated with imaging a wide variety of materials, as well as taking those solutions to market and are delighted to offer access to this expertise via our new Advanced Technology Group.”

Paul Ellwood, Managing Director of Synoptics added: “Over 25 years of applying imaging technologies has provided Synoptics with an excellent insight into what we can deliver in a specific timeframe. We encourage academic researchers experiencing issues with their biological imaging processes, or technology providers that are looking to design an imaging system to bring to market, to contact us today to discuss how working with our new Advanced Technology Group could help them make a strategic impact on their research or quality control objectives.”